BioHarvest Sciences (NASDAQ:BHST) Shares Up 3% – Here’s What Happened

BioHarvest Sciences Inc. (NASDAQ:BHST)’s share price traded up 3% during trading on Tuesday . The company traded as high as $6.12 and last traded at $6.12. 12,484 shares traded hands during mid-day trading, an increase of 63% from the average session volume of 7,662 shares. The stock had previously closed at $5.94.

Analyst Upgrades and Downgrades

Several analysts have recently commented on BHST shares. HC Wainwright assumed coverage on BioHarvest Sciences in a report on Friday, December 6th. They set a “buy” rating and a $14.00 target price on the stock. Maxim Group initiated coverage on shares of BioHarvest Sciences in a research report on Wednesday, December 18th. They issued a “buy” rating and a $12.00 price objective for the company.

BioHarvest Sciences Stock Up 3.9 %

The stock’s 50-day simple moving average is $5.58. The stock has a market cap of $104.96 million, a PE ratio of -5.12 and a beta of 2.27.

Hedge Funds Weigh In On BioHarvest Sciences

An institutional investor recently bought a new position in BioHarvest Sciences stock. TD Waterhouse Canada Inc. bought a new stake in shares of BioHarvest Sciences Inc. (NASDAQ:BHST) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 12,042 shares of the company’s stock, valued at approximately $69,000. TD Waterhouse Canada Inc. owned 0.07% of BioHarvest Sciences at the end of the most recent quarter.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.